30 Mar
2021

Latest Humira dispute highlights biosimilar trade secrets dangers

AbbVie’s clash with an adalimumab biosimilar producer is the latest in a string of lawsuits showing why biologics originators and imitators need strategies to protect proprietary information

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth